Minute Book, home
Coroner’s reportPrevention of future deaths · 2025-0007

“Whether there is adequate communication of the risks of suicide associated with the…”

Dated 7 Jan 2025, from the coroner for Gloucestershire. Sent to 3 organisations or people.

A coroner wrote this report after an inquest, to warn the organisations below about a risk of further deaths.

Read the full report on judiciary.uk

How this works

The 56-day response deadline

Deadline passed

Replies were due by 4 Mar 2025. A reply may have been sent and not yet published.

Organisations that receive a report must reply to the coroner within 56 days, saying what they will do or why they will do nothing. We show whether a response is published on judiciary.uk.

  1. Report dated7 Jan 2025
  2. Deadline4 Mar 2025
  3. Published on judiciary.uk9 Jan 2025
  4. Today28 Oct 2026

Watch this report

We’ll email you when a response is published on judiciary.uk, or when the 56 days to reply end with none published there yet. Free, and you can stop with one click.

Next we ask your name, then send a link to confirm and create your free account. Already have an account? Sign in

Responses from each recipient

Responses from each recipient
Sent toResponse
National Institute for Health and Care ExcellenceResponse publishedPublished on judiciary.uk in January 2025.
Medicines and Healthcare products Regulatory AgencyNamed in the report as “Medicines and Healthcare Products Regulatory Agency”Response publishedPublished on judiciary.uk in January 2025.
Royal College of General PractitionersResponse published, not yet matchedA response is published with this report. We haven’t yet matched it to the organisation it’s from, so it may be this one’s.

Some responses were published as scans, so their text was read automatically. Check the wording against the original before you quote it.

The coroner’s concerns

– 1. Whether there is adequate communication of the risks of suicide associated with the selective serotonin reuptake inhibitor (SSRI) medications, and 2. Whether the current guidance to persist with SSRI medication or switch to an alternative SSRI medication is appropriate when no benefit has been achieved and/ or especially when any adverse side effects are being experienced.

An extract. Read the full report, including the circumstances of the death, on the Courts and Tribunals Judiciary website.

Source
judiciary.uk, Prevention of Future Deaths reports, 2025-0007
Added to Minute Book
8 Oct 2026
Reuse
We show short extracts and link to the original. We don’t host the full report.

Something wrong, such as a date or who it was sent to? Report a mistake

Is this report about someone close to you? You can ask us to remove names from our pages.

Contains public sector information licensed under the Open Government Licence v3.0. Source: Courts and Tribunals Judiciary, judiciary.uk. Open Government Licence v3.0

Ask about this report

AI

Summaries and questions, with page references. Pro and above.

Sign in to use